Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 November 2023 | Story Valentino Ndaba
General Post, GRADS DEC 2023
It’s time for the UFS’s December graduation ceremonies!

Esteemed guest speakers

Tirelo Sibisi, Vice-Chairperson of the UFS Council, will be the distinguished guest speaker on the first day of graduations. Sibisi boasts an illustrious career, with over two decades of experience in human resource management, including notable roles at AngloGold Ashanti, the country's biggest cement manufacturer (PPC Cement), IBM, and Telkom. Her contributions extend to various boards and committees, showcasing her expertise and dedication to various fields.

Dr Anchen Laubscher, who also serves on the UFS Council, will take the stage as guest speaker on the second day. Dr Laubscher is currently the Group Medical Director of Netcare Ltd, leading the strategic oversight and operational execution of clinical and quality-related matters. Her commitment to healthcare excellence and leadership, coupled with being the first female President of the UFS Student Representative Council (SRC), exemplifies her remarkable achievements.

Chancellor’s Medallist

Professor Mattheus Lötter is set to finally receive the prestigious Chancellor’s Medal from the Faculty of Health Sciences. This conferral was postponed from the April 2023 graduation ceremonies due to a personal loss experienced by Prof Lötter. This will mark a pivotal point in his distinguished career, allowing him to celebrate a noteworthy accomplishment.

Details of the ceremonies

The festivities are set to commence on 7 December 2023, starting at 09:00 with the graduations for the Faculty of The Humanities, Faculty of Natural and Agricultural Sciences, and the Faculty of Theology and Religion. The day concludes with ceremonies for the Faculty of Education, Faculty of Economic and Management Sciences, and the Faculty of Law, all beginning at 14:30.

The celebration continues on 8 December 2023, at 09:00, as graduands from the Faculty of Health Sciences proudly take the stage.

For further information and updates on the UFS 2023 December graduation ceremonies, click here

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept